Exhibit 99
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND MAJOR PRODUCT GROUPS
Three Months Ended June 30,
(Unaudited; Amounts in thousands)
United States
2003 2002 % Change
-------------------------------------------
BD MEDICAL SYSTEMS
Medical Surgical $190,831 $175,185 * 8.9
Consumer Health Care 81,329 70,122 * 16.0
Pharmaceutical Systems 28,029 19,909 40.8
Ophthalmic Systems 5,847 6,804 (14.1)
- ---------------------------------------------------------------------------------
TOTAL $306,036 $272,020 12.5
- ---------------------------------------------------------------------------------
BD CLINICAL LABORATORY SOLUTIONS
Preanalytical Solutions $102,869 $ 97,306 5.7
Diagnostic Systems 88,019 77,670 13.3
- ---------------------------------------------------------------------------------
TOTAL $190,888 $174,976 9.1
- ---------------------------------------------------------------------------------
BD BIOSCIENCES
Discovery Labware $ 25,053 $ 26,643 (6.0)
Immunocytometry & Reagents:
Flow Cytometry Instruments
& Reagents 34,960 27,668 26.4
Molecular Biology Reagents 8,091 10,187 * (20.6)
Immunology/Cell Biology Reagents 18,060 17,155 5.3
- ---------------------------------------------------------------------------------
Total Immunocytometry & Reagents 61,111 55,010 * 11.1
- ---------------------------------------------------------------------------------
TOTAL $ 86,164 $ 81,653 * 5.5
- ---------------------------------------------------------------------------------
TOTAL UNITED STATES $583,088 $528,649 * 10.3
- ---------------------------------------------------------------------------------
* Prior year data reclassified to conform to current year presentation
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND MAJOR PRODUCT GROUPS
Three Months Ended June 30, (continued)
(Unaudited; Amounts in thousands)
International
------------------------------------------------------------------
% Change
----------------------
2003 2002 Reported FX Neutral FX Impact
------------------------------------------------------------------
BD MEDICAL SYSTEMS
Medical Surgical $179,543 $148,457 20.9 12.8 8.1
Consumer Health Care 55,785 45,361 23.0 10.5 12.5
Pharmaceutical Systems 99,319 71,210 39.5 17.5 22.0
Ophthalmic Systems 7,745 7,128 8.7 (5.4) 14.1
- --------------------------------------------------------------------------------------------------------
TOTAL $342,392 $272,156 25.8 13.1 12.7
- --------------------------------------------------------------------------------------------------------
BD CLINICAL LABORATORY SOLUTIONS
Preanalytical Solutions $ 77,503 $ 65,551 18.2 5.8 12.4
Diagnostic Systems 69,792 57,503 21.4 9.0 12.4
- --------------------------------------------------------------------------------------------------------
TOTAL $147,295 $123,054 19.7 7.3 12.4
- --------------------------------------------------------------------------------------------------------
BD BIOSCIENCES
Discovery Labware $ 21,596 $ 16,993 27.1 13.1 14.0
Immunocytometry & Reagents:
Flow Cytometry Instruments
& Reagents 49,121 38,659 27.1 11.2 15.9
Molecular Biology Reagents 7,720 8,021 * (3.8) (14.0) 10.2
Immunology/Cell Biology Reagents 14,157 10,928 29.5 13.7 15.8
- --------------------------------------------------------------------------------------------------------
Total Immunocytometry & Reagents 70,998 57,608 * 23.2 8.1 15.1
- --------------------------------------------------------------------------------------------------------
TOTAL $ 92,594 $ 74,601 * 24.1 9.3 14.8
- --------------------------------------------------------------------------------------------------------
TOTAL INTERNATIONAL $582,281 $469,811 * 23.9 11.0 12.9
- --------------------------------------------------------------------------------------------------------
* Prior year data reclassified to conform to current year presentation
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND MAJOR PRODUCT GROUPS
Three Months Ended June 30, (continued)
(Unaudited; Amounts in thousands)
Total
-------------------------------------------------------------------
% Change
-----------------------
2003 2002 Reported FX Neutral FX Impact
-------------------------------------------------------------------
BD MEDICAL SYSTEMS
Medical Surgical $ 370,374 $323,642 * 14.4 10.7 3.7
Consumer Health Care 137,114 115,483 * 18.7 13.8 4.9
Pharmaceutical Systems 127,348 91,119 39.8 22.6 17.2
Ophthalmic Systems 13,592 13,932 (2.4) (9.6) 7.2
- --------------------------------------------------------------------------------------------------------
TOTAL $ 648,428 $544,176 19.2 12.8 6.4
- --------------------------------------------------------------------------------------------------------
BD CLINICAL LABORATORY SOLUTIONS
Preanalytical Solutions $ 180,372 $162,857 10.8 5.8 5.0
Diagnostic Systems 157,811 135,173 16.7 11.5 5.2
- --------------------------------------------------------------------------------------------------------
TOTAL $ 338,183 $298,030 13.5 8.4 5.1
- --------------------------------------------------------------------------------------------------------
BD BIOSCIENCES
Discovery Labware $ 46,649 $ 43,636 6.9 1.5 5.4
Immunocytometry & Reagents:
Flow Cytometry Instruments
& Reagents 84,081 66,327 26.8 17.5 9.3
Molecular Biology Reagents 15,811 18,208 (13.2) (17.7) 4.5
Immunology/Cell Biology Reagents 32,217 28,083 14.7 8.6 6.1
- --------------------------------------------------------------------------------------------------------
Total Immunocytometry & Reagents 132,109 112,618 17.3 9.6 7.7
- --------------------------------------------------------------------------------------------------------
TOTAL $ 178,758 $156,254 14.4 7.3 7.1
- --------------------------------------------------------------------------------------------------------
TOTAL REVENUES $1,165,369 $998,460 16.7 10.6 6.1
- --------------------------------------------------------------------------------------------------------
* Prior year data reclassified to conform to current year presentation
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND MAJOR PRODUCT GROUPS
Nine Months Ended June 30,
(Unaudited; Amounts in thousands)
United States
----------------------------------------
2003 2002 % Change
----------------------------------------
BD MEDICAL SYSTEMS
Medical Surgical $ 564,313 $ 512,264 * 10.2
Consumer Health Care 240,483 209,337 * 14.9
Pharmaceutical Systems 72,351 50,827 42.3
Ophthalmic Systems 18,109 19,567 (7.5)
- -------------------------------------------------------------------------------
TOTAL $ 895,256 $ 791,995 13.0
- -------------------------------------------------------------------------------
BD CLINICAL LABORATORY SOLUTIONS
Preanalytical Solutions $ 306,850 $ 277,118 10.7
Diagnostic Systems 281,776 263,748 6.8
- -------------------------------------------------------------------------------
TOTAL $ 588,626 $ 540,866 8.8
- -------------------------------------------------------------------------------
BD BIOSCIENCES
Discovery Labware $ 71,399 $ 72,545 (1.6)
Immunocytometry & Reagents:
Flow Cytometry Instruments
& Reagents 87,300 88,078 (0.9)
Molecular Biology Reagents 24,353 30,668 * (20.6)
Immunology/Cell Biology Reagents 50,994 48,413 5.3
- -------------------------------------------------------------------------------
Total Immunocytometry & Reagents 162,647 167,159 * (2.7)
- -------------------------------------------------------------------------------
TOTAL $ 234,046 $ 239,704 * (2.4)
- -------------------------------------------------------------------------------
TOTAL UNITED STATES $1,717,928 $1,572,565 * 9.2
- -------------------------------------------------------------------------------
* Prior year data reclassified to conform to current year presentation
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND MAJOR PRODUCT GROUPS
Nine Months Ended June 30, (continued)
(Unaudited; Amounts in thousands)
International
-----------------------------------------------------------------
% Change
---------------------
2003 2002 Reported FX Neutral FX Impact
-----------------------------------------------------------------
BD MEDICAL SYSTEMS
Medical Surgical $ 492,978 $ 438,598 12.4 6.8 5.6
Consumer Health Care 150,008 136,800 9.7 1.2 8.5
Pharmaceutical Systems 262,048 190,776 37.4 19.8 17.6
Ophthalmic Systems 21,594 19,421 11.2 (0.5) 11.7
- -------------------------------------------------------------------------------------------------------
TOTAL $ 926,628 $ 785,595 18.0 8.8 9.2
- -------------------------------------------------------------------------------------------------------
BD CLINICAL LABORATORY SOLUTIONS
Preanalytical Solutions $ 216,782 $ 188,802 14.8 5.0 9.8
Diagnostic Systems 221,229 180,768 22.4 13.4 9.0
- -------------------------------------------------------------------------------------------------------
TOTAL $ 438,011 $ 369,570 18.5 9.1 9.4
- -------------------------------------------------------------------------------------------------------
BD BIOSCIENCES
Discovery Labware $ 60,511 $ 49,566 22.1 11.3 10.8
Immunocytometry & Reagents:
Flow Cytometry Instruments
& Reagents 144,313 123,604 16.8 4.6 12.2
Molecular Biology Reagents 24,501 23,999 * 2.1 (6.8) 8.9
Immunology/Cell Biology Reagents 39,166 31,478 24.4 11.5 12.9
- -------------------------------------------------------------------------------------------------------
Total Immunocytometry & Reagents 207,980 179,081 * 16.1 4.3 11.8
- -------------------------------------------------------------------------------------------------------
TOTAL $ 268,491 $ 228,647 * 17.4 5.8 11.6
- -------------------------------------------------------------------------------------------------------
TOTAL INTERNATIONAL $1,633,130 $1,383,812 * 18.0 8.4 9.6
- -------------------------------------------------------------------------------------------------------
* Prior year data reclassified to conform to current year presentation
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND MAJOR PRODUCT GROUPS
Nine Months Ended June 30, (continued)
(Unaudited; Amounts in thousands)
Total
-----------------------------------------------------------------
% Change
---------------------
2003 2002 Reported FX Neutral FX Impact
-----------------------------------------------------------------
BD MEDICAL SYSTEMS
Medical Surgical $1,057,291 $ 950,862 * 11.2 8.6 2.6
Consumer Health Care 390,491 346,137 * 12.8 9.5 3.3
Pharmaceutical Systems 334,399 241,603 38.4 24.5 13.9
Ophthalmic Systems 39,703 38,988 1.8 (4.0) 5.8
- -------------------------------------------------------------------------------------------------------
TOTAL $1,821,884 $1,577,590 15.5 10.9 4.6
- -------------------------------------------------------------------------------------------------------
BD CLINICAL LABORATORY SOLUTIONS
Preanalytical Solutions $ 523,632 $ 465,920 12.4 8.4 4.0
Diagnostic Systems 503,005 444,516 13.2 9.5 3.7
- -------------------------------------------------------------------------------------------------------
TOTAL $1,026,637 $ 910,436 12.8 8.9 3.9
- -------------------------------------------------------------------------------------------------------
BD BIOSCIENCES
Discovery Labware $ 131,910 $ 122,111 8.0 3.7 4.3
Immunocytometry & Reagents:
Flow Cytometry Instruments
& Reagents 231,613 211,682 9.4 2.3 7.1
Molecular Biology Reagents 48,854 54,667 (10.6) (14.5) 3.9
Immunology/Cell Biology Reagents 90,160 79,891 12.9 7.8 5.1
- -------------------------------------------------------------------------------------------------------
Total Immunocytometry & Reagents 370,627 346,240 7.0 0.9 6.1
- -------------------------------------------------------------------------------------------------------
TOTAL $ 502,537 $ 468,351 7.3 1.6 5.7
- -------------------------------------------------------------------------------------------------------
TOTAL REVENUES $3,351,058 $2,956,377 13.4 8.8 4.6
- -------------------------------------------------------------------------------------------------------
* Prior year data reclassified to conform to current year presentation